<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20" class="p">The oral administration of EPA-rich oil decreased the percentage of CD45
 <sup class="sup">+</sup>F4/80
 <sup class="sup">+</sup>CD11c
 <sup class="sup">+</sup> cells (3
 <sup class="sup">rd</sup> day) and increased the percentage of CD45
 <sup class="sup">+</sup>F4/80
 <sup class="sup">+</sup>CD206
 <sup class="sup">+</sup> cells in scar tissue at the 3
 <sup class="sup">rd</sup> and 10
 <sup class="sup">th</sup> days after wounding (Fig. 
 <xref rid="Fig3" ref-type="fig" class="xref">3B,C</xref>). These results suggest an anti-inflammatory effect of EPA during the tissue repair. No alterations were observed in percentage of CD45
 <sup class="sup">+</sup>TCRb
 <sup class="sup">+</sup>CD4
 <sup class="sup">+</sup> and CD45
 <sup class="sup">+</sup>TCRb
 <sup class="sup">+</sup>CD8
 <sup class="sup">+</sup> cells (Fig. 
 <xref rid="Fig3" ref-type="fig" class="xref">3C</xref>).
</p>
